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was found to be slightly different 
from other HEVs and included a 
putative ORF (ORF4) of 552 nt 
that overlapped with ORF1 (online 
Technical Appendix Figure). A similar 
pattern of genome organization was 
observed for both FRHEVs.
Phylogenetic analysis of the 
complete genomes clearly showed 
that FRHEV was separated from 
genotype 1–4 HEVs and clustered 
with rat HEV (Figure). Similar 
phylogenetic clustering was observed 
when nucleotide and deduced amino 
acid sequences of ORF1, ORF2, and 
ORF3 were analyzed separately. The 
phylogenetic distance between rat 
HEV and FRHEV is larger than the 
distance between genotype 1 and 
genotype 2 HEV.
In recent years, an increasing 
number of sporadic cases of 
hepatitis E have been reported (1,9). 
Several observations suggest that 
autochthonous cases are caused by 
zoonotic spread of infection from 
wild or domestic animals (1,3,9). In 
addition, IgG anti-HEV seropositivity 
in the United States has been associated 
with several factors, including having 
a pet at home (10). Further studies 
are needed to identify the zoonotic 
potential of FRHEV.
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diffi cile Ribotype 
027 in Chile 
To the Editor: The increased 
severity of Clostridium diffi cile 
infection is primarily attributed to 
the appearance of an epidemic strain 
characterized as PCR ribotype 027 
(1). The only report that identifi ed 
epidemic C. diffi cile ribotype 027 
in an American country outside of 
North America comes from Costa 
Rica, raising the possibility that 
strains 027 might also be present in 
other countries of Latin America (2). 
Several studies between 2001 and 
2009 have been conducted in South 
American countries to detect the 
incidence of C. diffi cile infection in 
hospitalized patients, but they did not 
identify which C. diffi cile strains were 
causing these infections (3).
During an epidemiologic 
screening of patients with C. diffi cile 
infection in a university hospital in 
Chile, we analyzed all stool samples 
of patients with suspected C. diffi cile 
infection during a 5-month period 
(June–November 2011).  Two cases of 
C. diffi cile infection were associated 
with ribotype 027.
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C. diffi cile was isolated from 
stool samples according to published 
protocols (4). Briefl y, stool samples 
were spread onto taurocholate-
cefoxitin-cycloserine fructose 
(Merck, Rahway, NJ, USA) agar 
plates and incubated for 96 hours 
at 37°C in a Bactron III-2 anaerobic 
workstation (SHEL LAB, Cornelius, 
OR, USA.). Plates were examined 
for the characteristic p-cresol odor 
unique to C. diffi cile culture (5). The 
aminopeptidase test (6) was also used 
to differentiate C. diffi cile strains. 
Suspected colonies were further 
analyzed by PCR to amplify tcdA, and 
tcdB genes (7). The presence of binary 
toxin gene (cdtB) and deletion in the 
negative regulator of the pathogenecity 
locus, tcdC, were determined by using 
Cepheid GeneXpert PCR (Cepheid, 
Sunnyvale, CA, USA). We used C. 
diffi cile ribotype 027 strain R20291 
as a reference strain for comparative 
purposes. PCR ribotyping was 
performed as described (8). The 
specifi c ribotype 027 of each of the 
clinical isolates was determined 
by visual analysis and with the 
GelCompar II v6.5 software (Applied 
Maths, St-Martens-Latem, Belgium).
Case-patient 1 was a 60-year-
old man with a history of coronary 
disease who required a coronary 
artery bypass graft because of 3-vessel 
coronary disease. Forty-eight hours 
after receiving 3 doses of cefazoline 
to prevent surgical wound infection, 
he exhibited severe and diffuse 
abdominal pain with frequent loose 
stools (8 bowel movements/day), 
fever (up to 39°C), and hemodynamic 
compromise, which required high 
doses of vasopressors. Stool samples 
were positive for C. diffi cile by 
ELISA, and the patient received 
intravenous metronidazole and oral 
vancomycin. However, because 
of the severity of the course of the 
disease, he underwent an urgent total 
colectomy with terminal ileostomy. 
The patient showed progressive 
improvement, and he was discharged 
11 days after surgery. No relapse of 
C. diffi cile infection was reported 
in this patient in the next 5 months. 
Isolation of toxigenic culture and 
PCR demonstrated that the bacterial 
pathogen causing the diarrhea was 
C. diffi cile ribotype 027 (i.e., strain 
PUC51) (Figure).
Case-patient 2 was a 46-year-
old man with a history of ischemic 
stroke with hemiparesis of the left 
side who had experienced a urinary 
tract infection that had been treated 
with ciprofl oxacin 2 months earlier. 
Four weeks before admission, he had 
frequent loose stools with no fever 
and diffuse abdominal pain after 
meals. On admission, a computed 
tomographic scan and angiograph of 
the abdomen showed pancolitis with 
colonic wall thickening and scant 
ascites, suggestive of an infl ammatory 
or infectious cause, without vascular 
compromise. However, ELISA 
of stool samples was negative for 
C. diffi cile toxin. Treatment with 
ceftriaxone reduced his symptoms, 
and he was discharged. Seven days 
after discharge, he had intense diffuse 
abdominal pain, with frequent loose 
stools and fever up to 38.9°C, and 
was again admitted to the hospital. 
A new computed tomographic scan 
of the abdomen showed no change; 
however, an ELISA of a new stool 
sample for C. diffi cile toxin was 
positive, and the patient was given 
oral vancomycin. No relapse of 
C. diffi cile infection was observed 
within 3 months of observation. 
Toxigenic culture from stool samples 
and PCR identifi ed the C. diffi cile 
isolate as ribotype 027 (i.e., strain 
PUC47) (Figure).
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Figure. Results of PCR ribotyping of Clostridium diffi cile 027 strains from Chile. M indicates 
the 100-bp DNA ladder; lane 2, R20291; lane 2, PUC47; lane 3, PUC51. A) PCR ribotyping 
of C. diffi cile isolates. PCR results show that that the band pattern of the ribosomal 
intergenic regions of strains PUC47 and PUC51 are similar to those of the reference 
(epidemic) strain R20291. B) Cluster analysis of strains PUC47, PUC51, and the epidemic 
strain 027 R20291 shows >99% similarity and that they belong to the same epidemic clade. 
Scale bar indicates percent identity.
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Molecular typing analysis 
showed that both case-patients had 
a monoclonal infection caused by C. 
diffi cile ribotype 027. Both isolates 
had tcdA, tcdB, and cdtB and had a 
deletion in tcdC (data not shown).
In summary, the described severe 
cases of C. diffi cile infection in Chile 
were caused by epidemic C. diffi cile 
ribotype 027. One of these case-
patients required urgent colectomy. 
These results demonstrate that 
epidemic C. diffi cile 027 strains are 
present in South America, highlighting 
the need for enhanced screening for 
this ribotype in other regions of the 
continent.
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To the Editor: Intense wildlife 
management for hunting affects risks 
associated with zoonotic pathogens 
(1). White-tailed deer (Odocoileus 
virginianus) are increasingly managed 
by fencing, feeding, watering, and 
translocation to increase incomes 
from hunting in northern Mexico (2). 
These deer also play a major role in 
dissemination and reintroduction of 
pathogens and vectors from Mexico 
into the United States (3,4). White-
tailed deer are suitable reservoir hosts 
for Mycobacterium bovis (1), and an 
M. bovis-positive white-tailed deer 
was recently found in Tamaulipas in 
northeastern Mexico (2). Brucellosis 
is widespread in many animal hosts 
in Latin America (5) and thus of 
interest in white-tailed deer. Another 
major zoonosis, sometimes linked 
to raw deer meat consumption, 
is hepatitis E, which is caused by 
genotypes of hepatitis E virus (HEV) 
(6). HEV is increasingly prevalent 
in red deer (Cervus elaphus) (7), but 
its prevalence in white-tailed deer is 
unknown.
The objective of this study was to 
determine the prevalence of zoonotic 
pathogens in white-tailed deer in 
northern Mexico. This study was 
conducted under a scientifi c collecting 
permit issued by the Mexican Division 
of Animal and Wildlife Health and 
on 8 ranches in 3 states in northern 
Mexico (≈26–28°N, 99–100°W). 
Serum samples (n = 347) 
were collected during 2004–2009 
in a cross-sectional survey for 
antibodies against HEV, Brucella 
spp., and mycobacteria.  Deer were 
opportunistically sampled during 
live-capture operations as described 
by Cantú et al. (8). Bleeding 
was performed by using jugular 
venipuncture and vacuum tubes 
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